A placebo-controlled, double-blind trial finds that teplizumab delays the onset of type 1 diabetes by a median of 2 years among high-risk individuals.
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023